ICCC insider filings
IMMUCELL CORP /DE/ — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-16. Screen ICCC transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| te Boekhorst Paul Francis Olivier — President and CEO, Director | 1 | — | — | 2 |
Recent insider filings — IMMUCELL CORP /DE/
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | te Boekhorst Paul Francis Olivier — President and CEO, Director | Option exercise (M): 16,393 @ $6.10 · Option exercise (M): 16,393 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | te Boekhorst Paul Francis Olivier — President and CEO, Director | Purchase (P): 8,000 @ $9.49 | EDGAR |
| 2026-04-16 | 4 | Basse Gloria F — Director | Grant/award (A): 11,933 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Turner Kathy V — Director | Grant/award (A): 17,899 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Wainman Paul R — Director | Grant/award (A): 11,933 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Tomsche David Scott — Director | Grant/award (A): 11,933 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | Gathagan Bryan K. — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | Basse Gloria F — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | Rosgen Steven T. — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | Wainman Paul R — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | Brockmann Bobbi Jo — VP of Sales and Marketing, Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | Tomsche David Scott — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | BRIGHAM MICHAEL F — Director | Option exercise (M): 25,000 @ $5.84 · Tax withholding (F): 24,052 @ $6.07 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4/A | te Boekhorst Paul Francis Olivier — President and CEO, Director | Grant/award (A): 109,500 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | te Boekhorst Paul Francis Olivier — President and CEO, Director | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | Fiori Timothy C — Chief Financial Officer, Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | Brockmann Bobbi Jo — VP of Sales and Marketing, Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-12-04 | 4/A | te Boekhorst Paul Francis Olivier — President and CEO, Director | Purchase (P): 3,598 @ $5.04 · Purchase (P): 2,432 @ $5.50 | EDGAR |
| 2025-12-03 | 4 | te Boekhorst Paul Francis Olivier — President and CEO, Director | Purchase (P): 3,708 @ $4.87 · Purchase (P): 2,556 @ $5.00 · Purchase (P): 3,521 @ $5.04 | EDGAR |
| 2025-11-28 | 4 | Tomsche David Scott — Director | Purchase (P): 1,633 @ $4.76 · Purchase (P): 1,633 @ $4.76 | EDGAR |
| 2025-11-12 | 4 | te Boekhorst Paul Francis Olivier — President and CEO, Director | Grant/award (A): 74,277 (derivative) @ $6.10 | EDGAR |
| 2025-06-13 | 4 | Basse Gloria F — Director | Option exercise (M): 3,530 @ $4.81 · Option exercise (M): 11,470 (derivative) @ $0 · Option exercise (M): 3.53 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Gathagan Bryan K. — Director | Purchase (P): 1,000 @ $6.32 | EDGAR |
| 2025-04-23 | 4 | Fiori Timothy C — Chief Financial Officer | Grant/award (A): 30,000 (derivative) @ $5.49 | EDGAR |
| 2024-09-24 | 4 | Gathagan Bryan K. — Director | Grant/award (A): 10,000 (derivative) @ $3.60 | EDGAR |
| 2024-09-24 | 4 | Basse Gloria F — Director | Grant/award (A): 10,000 (derivative) @ $3.60 | EDGAR |
| 2024-09-24 | 4 | Rosgen Steven T. — Director | Grant/award (A): 10,000 (derivative) @ $3.60 | EDGAR |
| 2024-09-24 | 4 | Wainman Paul R — Director | Grant/award (A): 10,000 (derivative) @ $3.60 | EDGAR |
| 2024-09-24 | 4 | Tomsche David Scott — Director | Grant/award (A): 10,000 (derivative) @ $3.60 | EDGAR |
| 2024-08-30 | 4 | Tomsche David Scott — Director | Disposition to issuer (D): 2,186 @ $3.55 | EDGAR |
| 2024-08-26 | 4 | Tomsche David Scott — Director | Disposition to issuer (D): 6,005 @ $3.55 | EDGAR |
| 2024-08-22 | 4 | Tomsche David Scott — Director | Disposition to issuer (D): 10,000 @ $3.55 | EDGAR |
| 2024-08-19 | 4 | Tomsche David Scott — Director | Disposition to issuer (D): 2,017 @ $3.57 · Disposition to issuer (D): 4,811 @ $3.72 · Disposition to issuer (D): 3,172 @ $3.67 | EDGAR |
| 2023-09-06 | 4 | Tomsche David Scott — Director | Disposition to issuer (D): 3,100 @ $4.75 | EDGAR |
| 2023-08-30 | 4 | Gathagan Bryan K. — Director | Grant/award (A): 15,000 (derivative) @ $5.11 | EDGAR |
| 2023-03-15 | 4 | Tomsche David Scott — Director | Disposition to issuer (D): 400 @ $5.20 · Disposition to issuer (D): 300 @ $5.24 · Disposition to issuer (D): 200 @ $5.25 · Disposition to issuer (D): 900 @ $5.37 · Disposition to issuer (D): 80 @ $5.34 · Disposition to issuer (D): 3 @ $5.24 · +19 more | EDGAR |
| 2023-01-24 | 4 | Basse Gloria F — Director | Grant/award (A): 10,000 (derivative) @ $6.52 | EDGAR |
| 2023-01-24 | 4 | Rosgen Steven T. — Director | Grant/award (A): 10,000 (derivative) @ $6.52 | EDGAR |
| 2023-01-24 | 4 | Wainman Paul R — Director | Grant/award (A): 10,000 (derivative) @ $6.52 | EDGAR |
| 2023-01-24 | 4 | Cunningham David — Director | Grant/award (A): 10,000 (derivative) @ $6.52 | EDGAR |
| 2023-01-24 | 4 | Tomsche David Scott — Director | Grant/award (A): 10,000 (derivative) @ $6.52 | EDGAR |
| 2022-09-12 | 4 | Tomsche David Scott — Director | Disposition to issuer (D): 306 @ $7.68 · Disposition to issuer (D): 329 @ $7.71 · Disposition to issuer (D): 5 @ $7.72 · Disposition to issuer (D): 5 @ $7.70 · Disposition to issuer (D): 260 @ $7.69 · Disposition to issuer (D): 1 @ $7.62 · +5 more | EDGAR |
| 2022-06-16 | 4 | Tomsche David Scott — Director | Disposition to issuer (D): 100 @ $8.27 · Disposition to issuer (D): 700 @ $8.25 · Disposition to issuer (D): 300 @ $8.23 · Disposition to issuer (D): 112 @ $8.20 · Disposition to issuer (D): 53 @ $8.18 · Disposition to issuer (D): 200 @ $8.64 · +13 more | EDGAR |
| 2022-06-14 | 4 | Cunningham David — Director | Purchase (P): 1,000 @ $8 | EDGAR |
| 2022-05-18 | 4 | Tomsche David Scott — Director | Disposition to issuer (D): 200 @ $8.35 · Disposition to issuer (D): 3,400 @ $8.37 | EDGAR |
| 2022-05-18 | 4/A | Tomsche David Scott — Director | Disposition to issuer (D): 200 @ $8.35 · Disposition to issuer (D): 3,400 @ $8.37 | EDGAR |
| 2022-05-18 | 4 | CRABB JOSEPH H — Former VP and CSO | Holdings only — no transactions reported | EDGAR |
| 2022-03-14 | 4 | CRABB JOSEPH H — Former VP and CSO | Disposition to issuer (D): 1,000 @ $5.84 | EDGAR |
| 2022-02-09 | 4 | Brockmann Bobbi Jo — VP of Sales & Marketing, Director | Grant/award (A): 18,000 (derivative) @ $8.15 | EDGAR |
| 2022-02-09 | 4 | BRIGHAM MICHAEL F — President & CEO, Director | Grant/award (A): 1,000 (derivative) @ $8.15 | EDGAR |
Recent 8-K events — IMMUCELL CORP /DE/
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-19 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-04-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ICCC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs